ACTIVE

NATESSENCE

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

-9,8 k €

-152.2% YoY

Gross margin

164,3 k €

-4.4% YoY

Equity

648,7 k €

-1.5% YoY

Workforce

0,9 ETP

+12.5% YoY

What does NATESSENCE do?

NATESSENCE is a Public limited company incorporated in 1993. Its registered office is in Ecaussinnes. It employs on average 0,9 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0449.788.802

Incorporation

29/03/1993

Legal form

Public limited company

Registered office

Rue de l'Avedelle 164
7190 Ecaussinnes · WallonieSee on map

Contributed capital

62 000,00 €

Latest accounts

31/12/2025

Average workforce

0,9 ETP

Joint committees (1)

Contacts

2 public details availableLog in to view

Signals

Solid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 21 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006		2005
Income statement
Gross margin	164,3 k €	-4.4%	172 k €	-42.8%	300,6 k €	-22.2%	386,4 k €	+3.6%	372,8 k €	+24.9%	298,5 k €	-10.1%	331,9 k €	-33.9%	502 k €	+130%	218,4 k €	+23.6%	176,7 k €	-0.7%	177,9 k €	+9.0%	163,3 k €	+13.9%	143,3 k €	-27.8%	198,6 k €	+21.1%	163,9 k €	+11.4%	147,2 k €	+11.9%	131,5 k €	+6.4%	123,6 k €	-19.8%	154,1 k €	+23.0%	125,3 k €	+3.1%	121,5 k €
EBITDA	109,5 k €	-14.9%	128,7 k €	-26.7%	175,5 k €	-32.4%	259,4 k €	+18.5%	218,9 k €	+14.4%	191,3 k €	-18.9%	235,9 k €	-39.4%	389 k €	+216%	123,1 k €	+73.0%	71,1 k €	-15.0%	83,7 k €	+18.4%	70,7 k €	+31.0%	54 k €	-51.5%	111,3 k €	+64.1%	67,8 k €	+17.7%	57,6 k €	+112%	27,1 k €	-30.2%	38,9 k €	-56.9%	90,3 k €	+22.3%	73,8 k €	+1.2%	72,9 k €
Operating result	11,2 k €	-61.7%	29,3 k €	-64.1%	81,6 k €	-27.0%	111,7 k €	+141%	46,4 k €	+274%	12,4 k €	-78.2%	57 k €	-75.8%	235,9 k €	+490%	40 k €	+20.4%	33,2 k €	+95.7%	17 k €	-67.6%	52,4 k €	+23.8%	42,3 k €	-58.4%	101,7 k €	+97.6%	51,4 k €	+8.1%	47,6 k €	+186%	16,6 k €	-19.7%	20,7 k €	-70.6%	70,4 k €	+27.7%	55,1 k €	+0.2%	55 k €
Net result	-9,8 k €	-152%	18,8 k €	-62.4%	50 k €	-31.8%	73,2 k €	+212%	23,5 k €	+155%	9,2 k €	-77.8%	41,5 k €	-73.5%	156,7 k €	+769%	18 k €	-19.9%	22,5 k €	+89.7%	11,9 k €	-70.1%	39,7 k €	+27.1%	31,3 k €	-53.8%	67,7 k €	+102%	33,5 k €	+5.9%	31,6 k €	+96.1%	16,1 k €	+24.6%	12,9 k €	-74.9%	51,6 k €	+75.3%	29,5 k €	+16.0%	25,4 k €
Balance sheet
Equity	648,7 k €	-1.5%	658,5 k €	-20.6%	829,8 k €	+6.4%	779,8 k €	+10.4%	706,6 k €	+3.4%	683,1 k €	+1.4%	673,9 k €	+6.6%	632,4 k €	+32.9%	475,7 k €	+3.9%	457,6 k €	+5.2%	435,1 k €	+2.8%	423,2 k €	+10.4%	383,5 k €	+8.9%	352,2 k €	+23.8%	284,5 k €	+13.4%	251 k €	+14.4%	219,4 k €	+7.9%	203,3 k €	+6.8%	190,3 k €	+37.2%	138,7 k €	+27.0%	109,2 k €
Total assets	1,4 M €	+1.6%	1,4 M €	-16.7%	1,7 M €	-1.8%	1,7 M €	-1.6%	1,8 M €	-8.5%	1,9 M €	-4.7%	2 M €	-10.7%	2,3 M €	+72.8%	1,3 M €	+60.2%	813,1 k €	+5.2%	772,9 k €	+34.4%	575 k €	+18.0%	487,2 k €	+3.7%	469,7 k €	+1.4%	463,1 k €	-1.1%	468,4 k €	-0.8%	472,3 k €	+18.8%	397,7 k €	-0.2%	398,7 k €	-13.1%	458,6 k €	+19.7%	383,2 k €
Cash	182,8 k €	+54.4%	118,4 k €	-62.6%	316,5 k €	-27.8%	438,6 k €	+42.5%	307,7 k €	+95.8%	157,1 k €	+3.9%	151,2 k €	-65.9%	443,1 k €	+8122%	5,4 k €	-84.6%	35 k €	+220%	11 k €	-82.3%	62 k €	+287%	16 k €	-84.2%	101,7 k €	+1.9%	99,9 k €	+20.0%	83,2 k €	-0.2%	83,4 k €	+97.8%	42,2 k €	-15.0%	49,6 k €	-2.7%	51 k €	-43.2%	89,7 k €
Debts	752,1 k €	+4.9%	716,9 k €	-11.8%	812,7 k €	-10.1%	904,4 k €	-9.7%	1 M €	-15.6%	1,2 M €	-7.2%	1,3 M €	-17.8%	1,6 M €	+88.6%	825,1 k €	+133%	353,5 k €	+5.2%	336 k €	+121%	151,8 k €	+46.8%	103,4 k €	-10.3%	115,2 k €	-34.8%	176,5 k €	-17.5%	214,1 k €	-15.4%	252,9 k €	+30.1%	194,4 k €	-6.6%	208,3 k €	-34.8%	319,6 k €	+16.7%	274 k €
Other
Workforce	0,9 ETP	+12.5%	0,8 ETP	-55.6%	1,8 ETP	0.0%	1,8 ETP	-21.7%	2,3 ETP	+15.0%	2,0 ETP	+5.3%	1,9 ETP	-9.5%	2,1 ETP	+10.5%	1,9 ETP	+5.6%	1,8 ETP	0.0%	1,8 ETP	0.0%	1,8 ETP	0.0%	1,8 ETP	0.0%	1,8 ETP	-5.3%	1,9 ETP	-13.6%	2,2 ETP	+15.8%	1,9 ETP	0.0%	1,9 ETP	+26.7%	1,5 ETP	+50.0%	1,0 ETP	0.0%	1,0 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 100 k€ and 250 k€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 23 ended

Active mandates

CASSART PHARMA

Director · 0780.539.006

Represented by Cassart François Pierre

Active

Ended mandates

CASSART PHARMA

Director · since 28 décembre 2023 · until 28 décembre 2029 · 0780.539.006

Represented by François Cassart

Ended

Aline Cambier

Director · since 01 janvier 2023 · until 28 décembre 2023

Ended

Dimitri Cambier

Director · since 01 janvier 2023 · until 28 décembre 2023

Ended

Aline CAMBIER

Director · since 13 août 2020 · until 01 juin 2026

Ended

At this address

Other companies at this address

Company	CBE no.
GROUPE NATESSENCE● Active	1021.054.959

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	02/07/2026	01/07/2025	06/08/2024	29/08/2023	28/10/2022	17/08/2021
General meeting	01/06/2026	02/06/2025	03/06/2024	05/06/2023	05/10/2022	07/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

21 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	01/06/2026	02/07/2026	French	PDF
Abridged model	31/12/2024	02/06/2025	01/07/2025	French	PDF
Abridged model	31/12/2023	03/06/2024	06/08/2024	French	PDF
Abridged model	31/12/2022	05/06/2023	29/08/2023	French	PDF
Abridged model	31/12/2021	05/10/2022	28/10/2022	French	PDF
Abridged model	31/12/2020	07/06/2021	17/08/2021	French	PDF
Abridged model	31/12/2019	13/08/2020	22/09/2020	French	PDF
Abridged model	31/12/2018	08/08/2019	09/08/2019	French	PDF
Abridged model	31/12/2017	10/08/2018	30/08/2018	French	PDF
Abridged model	31/12/2016	12/07/2017	17/07/2017	French	PDF
Abridged model	31/12/2015	25/08/2016	26/08/2016	French	PDF
Abridged model	31/12/2014	01/06/2015	23/07/2015	French	PDF
Abridged model	31/12/2013	02/06/2014	30/07/2014	French	PDF
Abridged model	31/12/2012	03/06/2013	20/06/2013	French	PDF
Abridged model	31/12/2011	04/06/2012	22/06/2012	French	PDF
Abridged model	31/12/2010	11/06/2011	13/07/2011	French	PDF
Abridged model	31/12/2009	12/06/2010	16/06/2010	French	PDF
Abridged model	31/12/2008	13/06/2009	29/07/2009	French	PDF
Abridged model	31/12/2007	30/04/2008	30/09/2008	French	PDF
Abridged model	31/12/2006	30/04/2007	24/06/2008	French	PDF
Abridged model	31/12/2005	14/06/2006	20/06/2008	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 k€ and 250 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 23 ended

Active mandates

CASSART PHARMA

Director · 0780.539.006

Represented by Cassart François Pierre

Active

Ended mandates

CASSART PHARMA

Director · since 28 décembre 2023 · until 28 décembre 2029 · 0780.539.006

Represented by François Cassart

Ended

Aline Cambier

Director · since 01 janvier 2023 · until 28 décembre 2023

Ended

Dimitri Cambier

Director · since 01 janvier 2023 · until 28 décembre 2023

Ended

Aline CAMBIER

Director · since 13 août 2020 · until 01 juin 2026

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates28/12/2023
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - DEMISSIONS, NOMINATIONS
PDF
Mandates23/10/2023
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
PDF
Mandates01/10/2020
DEMISSIONS, NOMINATIONS
PDF
Registered office07/01/2019
SIEGE SOCIAL
PDF
Mandates05/06/2018
DEMISSIONS, NOMINATIONS
PDF
Mandates11/01/2012
CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS - ANNEE COMPTABLE - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025-9,8 k €↓
2024
Annual accounts 202418,8 k €↓
2023
Annual accounts 202350 k €↓
2023
Name changePharamcie Natessence
2022
Annual accounts 202273,2 k €↑
2021
Annual accounts 202123,5 k €↑
2020
Annual accounts 20209,2 k €↓
2019
Annual accounts 201941,5 k €↓
2018
Annual accounts 2018156,7 k €↑
2017
Annual accounts 201718 k €↓
2016
Annual accounts 201622,5 k €↑
2015
Annual accounts 201511,9 k €↓
2014
Annual accounts 201439,7 k €↑
2013
Annual accounts 201331,3 k €↓
2012
Annual accounts 201267,7 k €↑
2011
Annual accounts 201133,5 k €↑
2010
Annual accounts 201031,6 k €↑
2009
Annual accounts 200916,1 k €↑
2008
Annual accounts 200812,9 k €↓
2007
Annual accounts 200751,6 k €↑
2006
Annual accounts 200629,5 k €↑
2005
Annual accounts 200525,4 k €
2005
Name changeNATESSENCE
29/03/1993
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

NATESSENCE

Overview

What does NATESSENCE do?

Trend over 21 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline